UNITED STATES
           SECURITIES AND EXCHANGE COMMISSION

                  Washington, D.C. 20549
                       FORM 10-QSB

[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR
     15(d)OF THE SECURITIES AND EXCHANGE ACT OF
     1934 For the Quarter ended December 31, 2004

[ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d)
     OF THE EXCHANGE ACT
     For the transition period         to
                               ------    ------

       Commission file number -  000-28787

              Micro Laboratories, Inc.
    (Exact name of Registrant as specified
             in its charter)
<TABLE>

                         <c>                           <c>
  NEVADA                                            05-049-4587
 (State or other (Primary Standard Industrial    (I.R.S. Employer
jurisdictions      Classification Code Number)  Identification number)
of incorporation
or organization

                      29 Lakeside Drive,
                   Johnston, Rhode Island               02919
          (Address of principal executive offices)    (Zip Code)
</TABLE>
       Telephone:  (401) 949-3562
   (Registrant's telephone number,
     including area code)

Indicate by check mark whether the Registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities and
Exchange Act of 1934 during the preceding twelve months (or such
shorter period that the Registrant was required to file such reports),
and (2) has been subject to file such filing requirements for the past
thirty days.

Yes    x      No
    ------       ------
Indicate the number of shares outstanding of each of the issuer's
classes of common stock, as of the close of the period covered by this
report:

    49,957,500 Shares of Common Stock
               (Title of Class)

Transitional Small Business Disclosure Format
    Yes           No    x
       -------       -------



<PAGE>2
             Micro Laboratories, Inc.

PART I:  Financial Information

         ITEM 1 - Financial statements

         ITEM 2 - Management's' discussion and
                    analysis of financial
                    condition and results of
                    operations

         ITEM 3 - Controls and Procedures

PART II:      Other Information

         ITEM 6 - Exhibits and Reports on Form 8-K








<PAGE>3

                  PART I
         Item 1. Financial Statements:

                        Micro Laboratories, Inc.
                              Balance Sheet
                           December 31, 2004

                      ASSETS
                      ------
                                                         December 31,
                                                            2004
                                                         ------------
Current assets:
  Cash                                                   $      917
                                                         ----------
      Total current assets                                      917

Property and equipment, net of accumulated
  depreciation of $53,091                                         -

Other assets                                                  1,853
                                                         ----------
Total assets                                             $    2,770
                                                         ==========
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
  Accounts payable                                       $  399,796
  Accrued legal settlement                                   65,000
  Loans from related parties                                289,848
                                                         ----------
      Total current liabilities                             754,644


 Common stock, $.001 par value,
  50,000,000 shares authorized, 49,957,500
  shares issued and outstanding                              49,958
 Additional paid in capital                               3,174,460
   (Deficit)                                             (3,976,292)
                                                         ----------
                                                           (751,874)
                                                         ----------
                                                         $    2,770
                                                         ==========

           See accompanying notes to financial statements.




<PAGE>4

                       Micro Laboratories, Inc.
                       Statements of Operations
        Three and Nine Months Ended December 31, 2004 and 2003
<TABLE>
<CAPTION>
                                 Three Months Ended            Nine Months Ended
                                     December 31,                 December 31,
                                2004             2003         2004             2003
                               ------           ------       ------           ------

                            <c>                <c>          <c>             <c>
 Sales                      $    3,950       $    9,898   $   23,474      $   20,220

  Cost of Sales                      -            1,980        1,952           3,874
                            ----------       ----------    ---------       ---------
  Gross Profit                   3,950            7,918       21,522          16,346

 Operating expenses:
  Advertising expense                -               10            -              10
  Professional fees              7,423            1,950       28,483          15,422
  Rent paid to related parties   1,800                -        5,400               -
  Depreciation & amortization       80                -          240           2,668
  Office expenses                  667              671        1,134           4,219
  Telephone expense                630            2,222        1,029           7,356
  Other expenses                 4,327            3,658       10,554          14,829
                             ---------       ----------    ---------       ---------
                                14,927            8,511       46,840          44,504
                             ---------       ----------    ---------       ---------
(Loss) from operations
   and net (loss)           $  (10,977)      $     (593)  $  (25,318)     $  (28,158)
                            ==========       ==========   ==========      ==========

Per share information:
Basic and diluted (loss)
  per common share          $        -       $        -    $       -      $       -
                            ==========       ==========    =========      =========
Weighted average shares
  outstanding               49,957,500       49,957,500    3,174,460      3,174,460
                            ==========       ==========    =========      =========
</TABLE>
   See accompanying notes to financial statements.





<PAGE>5

                         Micro Laboratories, Inc.
                         Statements of Cash Flows
                   Nine Months December 31, 2004 and 2003
<TABLE>
<CAPTION>
                                                     Nine Months Ended
                                                       December 31,
                                                   2004            2003
                                                  ------          ------

                                                 <c>             <c>
Net income (loss)                              $  (25,318)  $  (28,158)
  Adjustments to reconcile net income to net
   cash provided by operating activities:
   Depreciation and amortization                       80        2,668
Changes in assets and liabilities:
(Increase) decrease in:
   Other assets-Inventory                          (1,828)           -
Increase (decrease) in:
   Accounts payable                                18,239            -
                                              -----------    ---------
  Total adjustments                                18,319          840
                                              -----------    ---------
  Net cash provided by (used in)
   operating activities                            (6,999)     (27,318)


Cash flows from financing activities:
   Loans (paid back) received to related parties    7,196        28,485
                                               ----------     ---------
  Net cash provided by (used in)
   financing activities                             7,196        28,485

Increase (decrease) in cash                           197         1,167
Cash and cash equivalents,
 beginning of period                                  560           277
                                               ----------     ---------
Cash and cash equivalents,
 end of period                                 $      757    $    1,444
                                               ==========    ==========
</TABLE>


See accompanying notes to financial statements.





<PAGE>6

                        Micro Laboratories, Inc.
                        Statements of Cash Flows
                  Nine Months Ended December 31, 2004 and 2003

                                                    Nine Months Ended
                                                      December, 31
                                                 2004            2003

Cash paid for interest                          $    -          $    -
Cash paid for income taxes                      $    -          $    -



<PAGE>7

Micro Laboratories, Inc.
Notes to Unaudited Financial Statements
December 31, 2004

Basis of presentation

The accompanying unaudited financial statements have been prepared in
accordance with generally accepted accounting principles for interim
financial information and with the instructions incorporated in
Regulation SB of the Securities and Exchange Commission.  Accordingly,
they do not include all of the information and footnotes required by
generally accepted accounting principles for complete financial
statements. In the opinion of management, all adjustments (consisting
of normal recurring adjustments and accruals) considered necessary for
a fair presentation have been included.

The results of operations for the periods presented are not necessarily
indicative of the results to be expected for the full year. The
accompanying financial statements should be read in conjunction with
the Company's financial statements for the year ended March 31, 2004
included in the Company's filing on Form 10-K.

Basic loss per share was computed using the weighted average number of
common shares outstanding.

The Company had an outstanding advance balance due to related parties
of $289,848 at December 2004.  The advance increased by $5,726 during
the three months ended December 31, 2004.







<PAGE>8

ITEM 2.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
AND RESULTS OF OPERATIONS

Trends and Uncertainties. Demand for Micro's products will be dependent
on, among other things, general economic conditions, which are cyclical
in nature. Inasmuch as a major portion of Micro's activities is the
receipt of revenues from the sale of its products, Micro's business
operations may be adversely affected by its competitors and prolonged
recessionary periods.

Capital and Source of Liquidity. Micro currently has no material
commitments for capital expenditures.

For the nine months ended December 31, 2004 and 2003, Micro did not
pursue any investing activities.

For the nine months ended December 31, 2004, Micro paid back loans from
related parties of $7,196 resulting in net cash used in financing
activities of $7,196.

For the nine months ended December 31, 2003, Micro received loans from
related parties of $28,485 resulting in net cash provided by financing
activities of $28,485.

On a long-term basis, liquidity is dependent on commencement of
operations as discussed above, receipt of revenues, additional
infusions of capital and debt financing.

Micro believes that additional capital and debt financing in the short
term will allow Micro to increase its marketing and sales efforts and
become a fully operational corporation thereafter resulting in
increased revenue and greater liquidity in the long term. However,
there can be no assurance that Micro will be able to obtain additional
equity or debt financing in the future, if at all.

Results of Operations. Micro is accurately classified as a development
stage corporation and has conducted startup and development operations
that include:
   - completed photo shoots, created corporation logos, brochures,
sales literature, product labels and packaging design, UPCs
   - prepared the product line of six items for distribution roll out



<PAGE>9

   - completed negotiations with three large distributors to include
west coast, mid west, and New England to represent and sell the
Company's product lines to national chains.

Micro's revenues did not materially increase for the nine months ended
December 31, 2004 compared to December 31, 2003.   Micro did have an
increase in professional fees from $15,422 for the nine months ended
December 31, 2003 to $28,483 for the nine months ended December 31,
2004 due to additional professional fees incurred to resolve an issue
with the prior auditor.   Additionally Micro paid rent to a related
party of $5,400 for the nine months ended December 31, 2004 compared to
$0 for the nine months ended December 31, 2003.   Micro significantly
decreased its office expenses and telephone expenses for the nine
months ended December 31, 2004 due to management's continued attempts
to decrease administrative costs.

Plan of Operation.   Micro is in the development stage and has not
conducted any significant operations to date or received any material
operating revenues. Micro has experienced problems, delays, expenses
and difficulties sometimes encountered by an enterprise in Micro's
stage of development, many of which are beyond Micro's control. These
include, but are not limited to, unanticipated problems relating to
additional costs and expenses that may exceed current estimates,
competition, product development and acceptance; and lack of
distribution channels.

Micro intends to market its products and services utilizing cash made
available from the private sale of its securities and operations.

Micro's management is currently looking for an acquisition candidate
and is of the opinion that the proceeds of the sales of its securities
and future revenues will not be sufficient to pay its expenses for the
next twelve months. Advances from its president will be required to
continue the minimal operations of Micro.



<PAGE>10

Item 3. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Our management, under the supervision and with the participation of our
chief executive officer and chief financial officer, conducted an
evaluation of our "disclosure controls and procedures" (as defined in
Securities Exchange Act of 1934 (the "Exchange Act") Rules 13a-14(c))
within 90 days of the filing date of this quarterly report on Form
10QSB (the "Evaluation Date").  Based on their evaluation, our chief
executive officer and chief financial officer have concluded that as of
the Evaluation Date, our disclosure controls and procedures are
effective to ensure that all material information required to be filed
in this quarterly report on Form 10QSB has been made known to them in a
timely fashion.

Changes in Internal Controls

There have been no significant changes (including corrective actions
with regard to significant deficiencies or material weaknesses) in our
internal controls or in other factors that could significantly affect
these controls subsequent to the Evaluation Date set forth above.







<PAGE>11

                    PART II
               OTHER INFORMATION

ITEM 1.  LEGAL PROCEEDINGS.

    Not applicable.

ITEM 2.  CHANGES IN SECURITIES.

    Not applicable.

ITEM 3.  DEFAULTS UPON SENIOR SECURITIES.

    Not applicable.

ITEM 4.  SUBMISSION OF MATTERS TO A VOTE OF
          SECURITY HOLDERS.

    Not applicable.

ITEM 5.  OTHER INFORMATION.

    Not applicable.

ITEM 6.  EXHIBITS AND REPORTS ON FORM 8-K.

(a)  Exhibit 31 - 302 Certification
(b)  Exhbiit 32 - 906 Certification

    (b)  Not applicable.




               SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf
by the undersigned thereunto duly authorized.


/s/ Robert Thistle
----------------------------
Robert Thistle, President


March 11, 2005